AI Validated for Precision HER2 Scoring in Breast Cancer
HER2 scoring is a critical biomarker assessment used in breast cancer treatment planning. An independent multi vendor study recently validated an AI driven approach for precision HER2 scoring. The study evaluated performance across multiple environments and demonstrated strong agreement with expert pathology interpretation.
Read the full BostonGene news article at https://bostongene.com/news-an....d-publications/news/